scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Tatva Chintan Pharma Chem Ltd

Feedback
Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd (TATVA) Share Price

  • Sector: Chemicals (Small Cap)
  • Volume: 81,485
Mar 13, 2025 15:51 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹637.00
₹-39.25 (-5.80%)
₹631.05 Low
Today’s Performance
₹684 High
₹631.05 Low
52 Week’s Performance
₹1320 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -5.80%
  • 1 Week -12.11%
  • 1 Month -14.33%
  • 3 Months -28.14%
  • 6 Months -34.60%
  • 1 Year -47.24%
  • 3 Years -33.55%
  • 5 Years 0.00%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.37
  • 52-Week Low (₹) 631.05
  • 52-Week High (₹) 1,320.00
  • Price-to-Book (X)* 2.02
  • Dividend Yield (%) 0.31
  • Price-to-Earnings (P/E) (X)* 104.38
  • Earnings Per Share (₹) 6.11
  • Sector Price Earning (X)* 44.28
  • Market Cap (₹ Cr.)* 1,490.07
  • * Vaues as of last close price

COMPETITORS

BT TV

Time To Reinvest? Expert's Insights On CPI Data, Dollar Index, And When To Start Investing Again 2:21 Time To Reinvest? Expert's Insights On CPI Data, Dollar Index, And When To Start Investing Again
Investing In Quality Stocks | Expert Reveals The Secrets To Identifying Top Picks 3:09 Investing In Quality Stocks | Expert Reveals The Secrets To Identifying Top Picks
Navneet Munot on Market Slowdown: Temporary or Trend?|FIIs Return|India vs China 2:13 Navneet Munot: 'India's fundamentals remain strong' despite recent FII outflows
Gold Vs. Uncertainty: Expert Insights On Investing In Gold Amidst Market Volatility 1:45 Gold Vs. Uncertainty: Expert Insights On Investing In Gold Amidst Market Volatility
Expert's Insights On Stock-Specific Investing Strategy In A Corrected Market 2:04 Expert's Insights On Stock-Specific Investing Strategy In A Corrected Market
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Aug 27, 2021 PURCHASE
GOLDMAN SACHS FUNDS GOLDMAN SACHS INDIA EQUITY PORTFOLIO
  • Qty 92339
  • Average Price ₹2,129.70
Aug 27, 2021 Sell
GOLDMAN SACHS INDIA FUND LIMITED
  • Qty 92339
  • Average Price ₹2,129.70
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Sep 06, 2023 Sell
AJAY MANSUKHLAL PATEL HUF
  • Qty 206366
  • Average Price ₹1,642.12
Sep 06, 2023 PURCHASE
DAKSHA DUSHYANT PATEL
  • Qty 124000
  • Average Price ₹1,646.03
Sep 06, 2023 Sell
DARSHANA NITINKUMAR SHAH
  • Qty 233766
  • Average Price ₹1,639.60
Sep 06, 2023 Sell
SHEKHAR RASIKLAL SOMANI
  • Qty 233767
  • Average Price ₹1,647.83
Jul 29, 2021 PURCHASE
VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITED
  • Qty 140469
  • Average Price ₹2,325.08
Jul 29, 2021 PURCHASE
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 581308
  • Average Price ₹2,337.65
Jul 29, 2021 PURCHASE
NUMIV RESEARCH PRIVATE LIMITED
  • Qty 247676
  • Average Price ₹2,317.81
Jul 29, 2021 PURCHASE
PLUTUS WEALTH MANAGEMENT LLP
  • Qty 650000
  • Average Price ₹2,171.74
Jul 29, 2021 PURCHASE
ALPHAGREP SECURITIES PRIVATE LIMITED
  • Qty 149145
  • Average Price ₹2,329.07
Jul 29, 2021 Sell
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 581308
  • Average Price ₹2,340.16
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Tatva Chintan Pharma Chem Ltd share price previously?
Tatva Chintan Pharma Chem Ltd share price was down by -5.80% from the previous closing price of ₹676.25.
Who are peers of Tatva Chintan Pharma Chem Ltd?
The peers of Tatva Chintan Pharma Chem Ltd are Pidilite Industries Ltd, SRF Ltd, Linde India Ltd, Gujarat Fluorochemicals Ltd, Godrej Industries Ltd, Deepak Nitrite Ltd, Navin Fluorine International Ltd,
Who is/are the promoter/promoters of Tatva Chintan Pharma Chem Ltd?
The promotor/promotors of Tatva Chintan Pharma Chem Ltd are Chintan Nitinkumar Shah, Ajaykumar Mansukhlal Patel, Shekhar Rasiklal Somani, Subhash Patel, Avani Rajesh Umatt, Manher Chinmanlal Desai, Ishwar Nayi.
What has been 52-week high of Tatva Chintan Pharma Chem Ltd stocks?
The highest price of Tatva Chintan Pharma Chem Ltd stock is ₹1,320.00 in the last 52-week.
What is the share price of Tatva Chintan Pharma Chem Ltd (TATVA) today on NSE?
As on Mar 13, 2025, Tatva Chintan Pharma Chem Ltd (TATVA)’s share price on NSE is Rs 637
What is the market cap of Tatva Chintan Pharma Chem Ltd (TATVA?)
The current market capitalisation of Tatva Chintan Pharma Chem Ltd (TATVA) is 1,490.07 crores
What is Tatva Chintan Pharma Chem Ltd Share symbol?
The symbol of Tatva Chintan Pharma Chem Ltd is TATVA.
What is the PE ratio of Tatva Chintan Pharma Chem Ltd (TATVA)?
The current PE ratio of Tatva Chintan Pharma Chem Ltd (TATVA) is 104.38.
What is the PB ratio of Tatva Chintan Pharma Chem Ltd (TATVA)?
The current PB ratio of Tatva Chintan Pharma Chem Ltd (TATVA) is 2.02.
Today’s High & Low share prices of Tatva Chintan Pharma Chem Ltd (TATVA) on NSE?
Today, the share price of Tatva Chintan Pharma Chem Ltd (TATVA) on NSE touched a high of Rs 684 and a low of Rs 631.05
What price did Tatva Chintan Pharma Chem Ltd (TATVA) shares open on the NSE today?
On NSE, the share price of Tatva Chintan Pharma Chem Ltd (TATVA) opened at Rs 672.2
What is the 52-week high of Tatva Chintan Pharma Chem Ltd (TATVA)?
The 52-week high price of Tatva Chintan Pharma Chem Ltd (TATVA) is Rs 1320
What is the 52-week low of Tatva Chintan Pharma Chem Ltd (TATVA) ?
The 52-week low price of Tatva Chintan Pharma Chem Ltd (TATVA) is Rs 631.05

ABOUT TATVA CHINTAN

Tatva Chintan Pharma Chem Ltd, incorporated in the year 1996, has its registered office in No 502/17 GIDC Estate, Ankleshwar, Bharuch, Gujarat, 393002, +91-75730-46951/46952. The main industry in which Tatva Chintan Pharma Chem Ltd operates is Chemicals.

Auditor/Auditors for Tatva Chintan Pharma Chem Ltd is/are NDJ & Co. In the main management, Chintan Nitinkumar Shah is chairman and Ishwar Nayi is the company secretary for Tatva Chintan Pharma Chem Ltd.

  • CNS Chintan Nitinkumar Shah Chairman & Managing Director
  • AMP Ajaykumar Mansukhlal Patel Whole-time Director
  • SRS Shekhar Rasiklal Somani Whole-time Director
  • SP Subhash Patel Independent Non Exe. Director
  • ARU Avani Rajesh Umatt Independent Non Exe. Director
  • MCD Manher Chinmanlal Desai Independent Non Exe. Director
  • IN Ishwar Nayi Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement